THERAPEUTIC DRUG MONITORING OF BIOLOGICS IN INFLAMMATORY BOWEL DISEASE: NORDIC SURVEY ON IMPLEMENTATION AND BARRIERS IN CLINICAL PRACTICE

被引：0
|
作者：
Bjorlykke, Kristin H.
Jahnsen, Jorgen
Brynskov, Jorn
Molander, Pauliina
Eberhardson, Michael
Davidsdottir, Loa G.
Sipponen, Taina
Hjortswang, Henrik
Langholz, Ebbe
Jorgensen, Kristin K.
Steenholdt, Casper
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1109
引用
收藏
页码：S506 / S506
页数：1
相关论文
共 50 条
  • [1] Therapeutic drug monitoring of biologics in Inflammatory Bowel Disease: Nordic survey on implementation and barriers in clinical practice
    Bjorlykke, K.
    Jahnsen, J.
    Brynskov, J.
    Molander, P.
    Eberhardson, M.
    Davidsdottir, L. G.
    Sipponen, T.
    Hjortswang, H.
    Langholz, E.
    Jorgensen, K. K.
    Steenholdt, C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I441 - I441
  • [2] Therapeutic drug monitoring of biologics in Inflammatory Bowel Disease: Nordic survey on implementation and barriers in clinical practice
    Bjorlykke, K.
    Jahnsen, J.
    Brynskov, J.
    Molander, P.
    Eberhardson, M.
    Davidsdottir, L. G.
    Sipponen, T.
    Hjortswang, H.
    Langholz, E.
    Jorgensen, K. K.
    Steenholdt, C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I441 - I441
  • [3] Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia
    Bjorlykke, Kristin H.
    Jahnsen, Jorgen
    Brynskov, Jorn
    Molander, Pauliina
    Eberhardson, Michael
    Davidsdottir, Loa G.
    Sipponen, Taina
    Hjortswang, Henrik
    Goll, Guro Lovik
    Syversen, Silje Watterdal
    Langholz, Ebbe
    Jorgensen, Kristin K.
    Steenholdt, Casper
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (01) : 25 - 33
  • [4] Therapeutic drug monitoring of biologics for inflammatory bowel disease
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Sandborn, William J.
    Van Assche, Gert
    Robinson, Anne M.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (02) : 349 - 358
  • [5] ATTITUDE AND BARRIERS TOWARDS THE IMPLEMENTATION OF THERAPEUTIC DRUG MONITORING OF ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE CLINICAL PRACTICE
    Grossberg, Laurie B.
    Papamichail, Konstantinos
    Feuerstein, Joseph D.
    Cheifetz, Adam S.
    GASTROENTEROLOGY, 2017, 152 (05) : S390 - S391
  • [6] Therapeutic Drug Monitoring in Practice for Inflammatory Bowel Disease
    Megna B.W.
    Vaughn B.P.
    Current Gastroenterology Reports, 2022, 24 (12) : 191 - 200
  • [7] Drug monitoring of biologics in inflammatory bowel disease
    Eser, Alexander
    Primas, Christian
    Reinisch, Walter
    CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (04) : 391 - 396
  • [8] Therapeutic Drug Monitoring of Biologics for Inflammatory Bowel Disease: An Answer to Optimized Treatment?
    Hoseyni, Hannah
    Xu, Yan
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (07): : 864 - 876
  • [9] Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: What, When and Why?
    Ashat, Divya
    Long, Millie D.
    PRACTICAL GASTROENTEROLOGY, 2021, 45 (07) : 22 - 27
  • [10] Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease
    Selinger, Christian P.
    Lenti, Marco V.
    Clark, Tanya
    Rafferty, Helen
    Gracie, David
    Ford, Alexander C.
    O'Connor, Anthony
    Ahmad, Tariq
    Hamlin, P. John
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (12) : 2083 - 2088
12345